TY - JOUR
T1 - Antiplatelet therapy
T2 - Does CYP2C19 genotype affect clinical outcome?
AU - Ten Berg, Jurriën M.
AU - Deneer, Vera H.
PY - 2012/4
Y1 - 2012/4
N2 - Commenting on the results of their meta-analysis, Holmes et al. suggest that CYP2C19 genotype does not affect clinical outcome in patients receiving clopidogrel therapy. However, we do not believe that the data support this conclusion; an association between genotype and outcome remains plausible and could be considered when choosing treatment.
AB - Commenting on the results of their meta-analysis, Holmes et al. suggest that CYP2C19 genotype does not affect clinical outcome in patients receiving clopidogrel therapy. However, we do not believe that the data support this conclusion; an association between genotype and outcome remains plausible and could be considered when choosing treatment.
UR - https://www.scopus.com/pages/publications/84859100321
U2 - 10.1038/nrcardio.2012.29
DO - 10.1038/nrcardio.2012.29
M3 - Review article
C2 - 22411289
AN - SCOPUS:84859100321
SN - 1759-5002
VL - 9
SP - 192
EP - 194
JO - Nature Reviews Cardiology
JF - Nature Reviews Cardiology
IS - 4
ER -